Ketamine molecule:

Image from PubChem

Ketamine Clinical Trials

Optimizing the Use of Ketamine to Reduce Chronic Postsurgical Pain

To see complete record on, please visit this link

Id: NCT05037123

Organisation Name: NYU Langone Health

Overal Status: Recruiting

Start Date: January 4, 2022

Last Update: October 13, 2022

Lead Sponsor: NYU Langone Health

Brief Summary: The study utilizes a 3-arm placebo-controlled RCT to study the effectiveness of ketamine in reducing chronic post-mastectomy pain. Participants randomized to the first arm will receive a 0.35 mg/kg dose after induction, followed by a 0.25 mg/kg/hr infusion during surgery (up to a maximum of 6 hours) and continued for 2 hours postoperatively. Participants in the second arm will receive a single dose of 0.6 mg/kg of ketamine in the post-anesthesia care unit, and the final group will serve as the control group and receive saline (no ketamine).

  • Chronic Postsurgical Pain

Total execution time in seconds: 0.47268891334534